Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted psychotherapy for gambling disorder (pilot)
2025-522743-18-00Phase 2Authorised
- Sponsor
- CHU de Nantes
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gambling disorder (GD) comparing Psilocybin-assisted psychotherapy with Placebo plus control sessions (2 arms). Primary endpoint: Protocol completion rate. Planned start Oct 2026; status: authorised.
02
Drugs
psilocybin
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on 2025-522743-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522743-18-00.